NCT04875364View on ClinicalTrials.gov

Do Endotypes Predict Response and Sequelae in OSA Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

January 1, 2027

Study Completion Date

January 1, 2027

Conditions
Obstructive Sleep ApneaSleep ApneaSleep Apnea, ObstructiveSleepSleep Disorder
Interventions
DRUG

Eszopiclone

2mg of Eszopiclone just before going to sleep.

OTHER

Supplemental Oxygen

Constant oxygen flow at 4 Liters per minutes for the duration of time in bed via nasal cannula.

DEVICE

Continuous Positive Airway Pressure (CPAP)

A standard CPAP device will be provided using the settings as prescribed by the treating physician.

Trial Locations (1)

92037

RECRUITING

Altman Clinical and Translational Research Institute Building, La Jolla

All Listed Sponsors
lead

University of California, San Diego

OTHER